Drug Information

Drug General Information
Drug ID
D0XB1M
Former ID
DIB008556
Drug Name
MSH-372
Synonyms
MIV-150; MIV-150)
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [524596]
Company
Medivir AB
Formula
C19H17FN4O3
Canonical SMILES
[C@@H]1([C@H](C1)NC(=O)Nc1ccc(cn1)C#N)c1c(c(ccc1F)C(=O)<br />CC)O
PubChem Compound ID
468179
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [550939]
References
Ref 524596ClinicalTrials.gov (NCT02033109) Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use. U.S. National Institutes of Health.
Ref 550939WO patent application no. 2004,0290,42, Pyrazole derivatives as reverse transcriptase inhibitors.